Skip to main content
USNA logo

USNA · Usana Health Sciences Inc

Track USNA — free
$13.37 -0.26 (-1.91%) At close · Aug 14
Market Cap
$247.03M
Shares
18.48M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$13.37 Open$13.76 Day$13.31–13.85 52W close$13.37–32.24 Avg vol 30d164K Short int690K · 3.7% float · 7.5d Short vol42% Last earningsAug 5, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 13

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 11 wks
FQ3-27 quarter ends
~Oct 3, 2026 Est
filed Aug 13, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Strong Sell Momentum Very Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Strong Sell
      50 / 200-day cross No cross
      Price vs 200-day avg −32%
      below
      Price vs 50-day avg −33%
      below
      RSI (14) 25
      oversold
      MACD trend Negative
      52-week position 0%
      near low
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Very Weak
      1-month return −39%
      trailing
      6-month return −39%
      trailing
      YTD return −32%
      this year
      Relative strength −53%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Distributing
      -4% holders QoQ · +23 funds added
      Insider flow Distributing
      Net -$543.9K over 90 days · 100% sells
      Short interest Falling
      3.74% of float · ▼ -8.3% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      134 holders — mid 3-yr range
      Squeeze score 55
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −11%
      Y/Y
      Gross margin 68%
      expanding
      EPS growth −74%
      Y/Y
      Free cash flow $8.5M
      Buyback $34.0M
      remaining
      Balance sheet $158.4M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 58%
      annualized · 1-yr
      Max drawdown −59%
      past year
      ATR 8.9%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed May 5, 2026
      Hiya net sales · fiscal year 2026 $140M – $155M
      Rise Wellness net sales · fiscal year 2026 $65M – $80M
      Consolidated net sales · fiscal year 2026 $925M – $1B
      Net earnings · fiscal year 2026 $20M – $27M
      Prior guidance period ended · from the Earnings Call filed Jan 31, 2024
      Hyatt revenue · 2025 $145M – $160M
      Capital expenditures as a percent of sales · 2025 1% – 1.5%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Strong Sell
      4 · 3 · 0
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −32% Bearish
      Price vs 50-day avg
      −33% Bearish
      RSI (14)
      25 Neutral
      MACD trend
      Negative Bearish
      52-week position
      0% Bearish
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $20 › 200d $20 — 50d above 200d
      Institutional flow Distributing
      -4% holders QoQ · +23 funds added
      Insider flow Distributing
      Net -$543.9K over 90 days · 100% sells
      Short interest Falling
      3.74% of float · ▼ -8.3% MoM · 7.5 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      134 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $13 Now $13 · 0% Range high $32
      vs 200-day avg -32% vs 50-day avg -33%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Adjusted diluted EPS non-GAAP -$0.07 Q2 2026
      Free cash flow $20M Q2 2026
      USANA Active Customers 387,000 FY 2025

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Packaged Foods — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      USNA
      Usana Health Sciences Inc
      this stock
      $247.03M -31.9% -10.8% 3.7%
      KHC
      Kraft Heinz Co
      $30.25B +5.2% -0.1% 7.3%
      GIS
      General Mills Inc
      $20.92B -15.7% +4.1% 9.2%
      MKC
      Mccormick & Co Inc
      $14.70B -19.7% +1.7% 9.1 5.1%
      JBS
      Jbs N.V.
      $14.62B -5.3% 3.3%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      134
      % held
      61.3%
      Net QoQ
      +1.0M sh
      Top holder
      BlackRock, Inc.
      Held Float
      View
      Held by Funds
      Fund positions
      185
      View
      Short & Settlement
      Short Interest Falling
      Shares short
      690.3K
      Days to cover
      7.5d
      Change
      -62.7K sh
      View
      Short Volume
      Short vol %
      42%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      5.8K
      Value
      $122.2K
      As of
      Jun 30, 2026
      View
      Off-Exchange
      Off-exchange %
      38.5%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Insider Trades Net selling
      Net (90d)
      -$543.9K
      Buyers / Sellers
      0 / 5
      Buyers Sellers
      View
      Financials
      Financials
      Revenue (FY)
      $925.3M
      Net income (FY)
      $10.8M
      EPS diluted
      $0.58
      View
      Buybacks
      Authorized
      $150.0M
      Remaining
      $34.0M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      10-Q
      Filed
      Aug 13, 2026
      This year
      11
      View
      Proposed Sales
      Value
      $97.3K
      Shares
      5.0K
      Filed
      Jun 16, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 5, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      USNA -13.6% -38.7% -38.7% -39.5% -31.9%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY -14.0% -43.2% -52.5% -43.5% -45.7%

      Capital returns

      Buyback program · as of Aug 4, 2026
      Authorized
      $150.00M
      Spent (derived)
      $116.00M
      Remaining
      $34.00M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 896264 CUSIP 90328M107 13F (30d) 129 filings 128 filers Visit website Investor relations